NPWT Market Overview
The negative pressure wound therapy (NPWT) is used in the treatment of various acute and chronic wounds. It is also referred as topical NPWT or vacuum-assisted wound closure procedure, which manage the wounds by applying sub-atmospheric pressure. These therapy-based NPWT devices mainly comprise semi-occlusive adhesive cover, open-pore polyurethane ether foam sponge, suction pump, and fluid collection system.
The NPWT devices market is driven by several factors, such as rising prevalence of diabetic foot ulcers; increasing government initiatives in the form of funds and grants for the management of chronic wounds; growing awareness towards management of wounds; and technological advancements.
Based on product, the negative pressure wound therapy market is segmented into single-use devices, conventional devices, and accessories. The conventional devices category is expected to hold the largest share during the forecast period. Increasing demand of conventional devices, as NPWT devices reduce complications, such as surgical site infections among the patients with chronic wounds, is a major factor supporting the growth of this category.
The NPWT market is segmented into surgical and traumatic wounds, burns, and ulcers, based on the wound type. The ulcer category is further bifurcated into diabetic foot ulcer, pressure ulcer, venous ulcer, and others. The surgical and traumatic wounds category is expected to hold the largest share during the forecast period, due to increasing prevalence of surgical site infections and chronic wounds across the globe.
The end-users in the NPWT industry include hospitals and home care settings. Other than these, nursing homes, and clinics also utilize these products. In 2017, hospitals was the largest end-user category in this market, and is expected to maintain this trend during the forecast period. This is due to increasing number of hospitals and rising number of patients with chronic wounds across the globe.
NPWT Market Dynamics
Increasing prevalence of diabetes is boosting the growth of the market
The NPWT market is growing due to increasing prevalence of diabetes, and rising usage of portable wound care devices. Moreover, increase in the number of hospitalization cases for chronic wounds, and rise in the initiatives implemented by the government organizations for the management of chronic wounds are also playing pivotal role in the growth of negative pressure wound therapy market.
According to the International Diabetes Federation (IDF), the global adult diabetic population reached to 425 million in 2017, and it is expected to reach around 629 million by 2045. Diabetic foot ulcer is a major complication of diabetes that could lead to leg amputation in severe cases, if left untreated. NPWT devices plays significant role in the management of diabetic foot ulcers, which increases its demand across the globe.
Furthermore, pressure ulcer is another medical condition that mainly occurs in the bedridden patients, who require this therapy for the complete treatment. Pressure ulcer blocks the circulation of blood flow to the affected areas which causes life-threatening blood poisoning. Thus, increasing prevalence of diabetic foot ulcers and pressure ulcers is increasing the demand for NPWT devices, globally.
Presence of lucrative opportunities in the emerging market
The changing market dynamics in the emerging countries, such as China and India, offer lucrative opportunities to the market players in NPWT industry. This is mainly due to the increasing incidence of acute and chronic wounds, increasing investment by international players, and government initiatives for the foreign direct investment in these nations.
NPWT Market Competitive Landscape
The companies operating in the NPWT market are launching novel products with technologically advanced features to increase their market share. For instance, in February 2018, Smith & Nephew plc introduced PICO 7, a single-use NPWT device in Europe. PICO 7 is a portable and clinically effective treatment for the chronic, acute and surgical wounds.
Some of the other key players operating in the NPWT industry are Acelity LP Inc., Mölnlycke Health Care AB, ConvaTec Inc., Cardinal Health Inc., DeRoyal Industries Inc., Lohmann & Rauscher GmbH & Co. KG, Talley Group Limited, Medela AG, and Genadyne Biotechnologies Inc.